Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In uniQure To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in uniQure between September 24, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Far ...

KLAR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Klarna Group plc (KLAR) Investors of Securities Class Action Deadline on February 20, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in [Klarna] pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Regist ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Allegations - Nidec Corporation is facing scrutiny after a report indicated that its shares dropped 22% following the announcement of a probe into improper accounting practices within its group [3]. - The investigation stems from allegations that Nidec may have misled investors regarding its financial status, which has led to significant losses for shareholders [1][3]. Group 2: Class Action and Compensation - Shareholders who purchased Nidec securities may be eligible for compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2]. - The Rosen Law Firm is preparing to file a class action to recover losses incurred by investors as a result of the alleged misleading information [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Lufax Holding Ltd due to allegations of materially misleading business information issued to the investing public [1] Group 1: Investigation Details - The investigation is focused on Lufax Holding Ltd (NYSE: LU) and its business practices [1] - Shareholders who purchased Lufax securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]

New York, New York--(Newsfile Corp. - February 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 13, 2026.SO WHAT: If you purchased uniQure ordinary shares during the Class P ...

Rosen Law Firm Encourages Franklin BSP Realty Trust, Inc. Investors to Inquire About Securities Class Action Investigation - FBRT [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) resulting from allegations that Franklin BSP Realty Trust, Inc. may have issued materially misleading business inf ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Investors who purchased PennyMac securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees, as the Rosen Law Firm is preparing to seek recovery of investor losses [2]. - To participate in the class action, investors can submit their information through the provided link or contact the firm directly [2]. Group 2: Financial Performance and Stock Impact - On January 29, 2026, PennyMac reported its fourth quarter and full-year 2025 financial results, revealing a significant decline in its servicing segment pretax income, which fell to $37.3 million from $157.4 million in the prior quarter and $87.3 million in the same quarter of 2024 [3]. - The report indicated that pretax income excluding valuation-related items was $47.8 million, a 70% decrease from the previous quarter, primarily due to increased realization of mortgage servicing rights cash flows as lower mortgage rates led to higher prepayment activity [3]. - Following the financial report, PennyMac's stock price dropped by $49.78 per share, or 33.3%, closing at $99.92 per share on January 30, 2026 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions of dollars for investors [4]. - The firm has been recognized for its achievements, including being ranked No. 1 for the number of securities class action settlements in 2017 and securing over $438 million for investors in 2019 [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against PayPal Holdings, Inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements about the company's salesforce and growth potential [3][5]. Group 1: Legal Investigation and Class Action - The firm is reminding investors of the April 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against PayPal [3]. - The complaint alleges that PayPal and its executives made false or misleading statements, leading to shareholders purchasing securities at artificially inflated prices [5]. Group 2: Financial Performance and Stock Impact - On February 3, 2026, PayPal reported weaker-than-expected fourth quarter earnings and revenue, alongside the announcement of CEO Alex Chriss's departure [6]. - Following this news, PayPal's stock price dropped by $10.63 per share, or 20.31%, closing at $41.70 per share [6]. Group 3: Investor Communication - Faruqi & Faruqi encourages anyone with information regarding PayPal's conduct, including whistleblowers and former employees, to contact the firm [8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against REGENXBIO Inc. due to allegations of violations of federal securities laws related to misleading statements about the efficacy and safety of its RGX-111 trial study [4][5]. Group 1: Legal Investigation - The firm is reminding investors of the April 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against REGENXBIO [4]. - The investigation follows a press release from REGENXBIO on January 28, 2026, announcing a clinical hold by the FDA on its RGX-111 investigational gene therapy due to a case of neoplasm in a trial participant [6]. - Following the announcement, REGENXBIO's stock price dropped by $2.40 per share, or 17.9%, closing at $11.01 per share [6]. Group 2: Company Background - REGENXBIO is involved in gene therapy, specifically targeting conditions such as MPS I (Hurler syndrome) and MPS II (Hunter syndrome) [6]. - The firm has recovered hundreds of millions of dollars for investors since its founding in 1995, indicating a strong track record in securities law [5].

SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Rob ...